Pharmaceutical Business Intelligence

  • Find generic sources and suppliers
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

Details for Patent: 6,339,105

« Back to Dashboard

Which drugs does patent 6,339,105 protect, and when does it expire?

Patent 6,339,105 protects ULTRAM and is included in one NDA.

Protection for ULTRAM has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

Summary for Patent: 6,339,105

Title: Analgesic regimen
Abstract:A regimen for the administration of tramadol for the treatment of analgesia is described. The regimen involves a slower initial titration rate of tramadol which results in a significantly lower percentage of discontinuations of therapy due to a lower incidence and severity of side effects.
Inventor(s): Kamin; Marc (West Windsor, NJ), Olson; William (Princeton, NJ)
Assignee: Ortho-McNeil Pharmaceutical, Inc. (Raritan, NJ)
Application Number:09/415,753
Patent Claim Types:
see list of patent claims
Use; Composition;

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Janssen Pharms
tramadol hydrochloride
TABLET;ORAL020281-002Mar 3, 1995RXYesYes6,339,105*PED► SubscribeY
Janssen Pharms
tramadol hydrochloride
TABLET;ORAL020281-001Mar 3, 1995DISCNNoNo6,339,105*PED► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.